RENVELA

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug RENVELA contains one active pharmaceutical ingredient (API):

1 Sevelamer
UNII 9YCX42I8IU - SEVELAMER CARBONATE

Sevelamer is a non-absorbed phosphate binding crosslinked polymer, free of metal and calcium. Sevelamer contains multiple amines separated by one carbon from the polymer backbone which become protonated in the stomach. These protonated amines bind negatively charged ions such as dietary phosphate in the intestine.

Read about Sevelamer

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RENVELA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
RENVELA Powder for oral suspension European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AE02 Sevelamer V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02354586, 02485559, 02485567
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1405-MEE-0915
Country: EE Ravimiamet Identifier(s): 1422414, 1422425, 1422436, 1422447, 1422458, 1422469, 1780578
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 09521003, 09521007, 109521008
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 036062, 036073, 478135
Country: FR Base de données publique des médicaments Identifier(s): 61136926, 63716917, 67392245
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 181374, 182911, 368724, 375943, 381660, 393546
Country: HK Department of Health Drug Office Identifier(s): 60178
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6690, 6691
Country: IT Agenzia del Farmaco Identifier(s): 039480037, 039480064
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1050558, 1050559, 1050560, 1050561, 1050562, 1050563, 1050564, 1086339, 1088300
Country: NL Z-Index G-Standaard, PRK Identifier(s): 207020, 90131, 90158
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100054613, 100075650, 100087854, 100412917
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W54577001, W54577002, W54577003, W54578001, W54578002, W54579001, W54579002
Country: SG Health Sciences Authority Identifier(s): 13725P
Country: US FDA, National Drug Code Identifier(s): 58468-0130, 58468-0131, 58468-0132
Country: ZA Health Products Regulatory Authority Identifier(s): 45/32.16/0305

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.